Patent classifications
C07F9/26
ELECTROLYTE SOLUTION FOR NON-AQUEOUS ELECTROLYTE BATTERY, AND NON-AQUEOUS ELECTROLYTE BATTERY USING THE SAME
The present invention provides an electrolyte solution for a non-aqueous electrolyte battery capable of an exerting high average discharge voltage and an excellent low-temperature output characteristic at 30 C. or lower and an excellent cycle characteristic and an excellent storage characteristic at high temperatures of 50 C. or higher, as well as a non-aqueous electrolyte battery containing the same. The present electrolyte solution comprises a non-aqueous solvent, a solute, at least one silane compound represented by the following general formula (1) as a first compound, and a fluorine-containing compound represented by the following general formula (3), for example, as a second compound.
Si(R.sup.1).sub.a(R.sup.2).sub.4-a(1)
##STR00001##
Ionic Complex, Electrolyte for Nonaqueous Electrolyte Battery, Nonaqueous Electrolyte Battery and Ionic Complex Synthesis Method
To provide a material suitable for a nonaqueous electrolyte battery having high-temperature durability. An ionic complex of the present invention is represented by any of the following formulae (1) to (3). For example, in the formula (1), A is a metal ion, a proton, or an onium ion; M is any of groups 13 to 15 elements. R.sup.1 represents a C.sub.1 to C.sub.10 hydrocarbon group which may have a ring, a heteroatom, or a halogen atom, or N(R.sup.2). R.sup.2 at this time represents hydrogen atom, alkali metal atom, a C.sub.1 to C.sub.10 hydrocarbon group which may have a ring, a heteroatom, or a halogen atom. R.sup.2 can also have a branched chain or a ring structure when the number of carbon atoms is 3 or more. Y is carbon atom or sulfur atom. a, o, n, p, q, and r are each predetermined integers.
##STR00001##
OLIGONUCLEOTIDE ANALOGUES HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS
Oligonucleotide analogues comprising modified intersubunit linkages and/or modified 3 and/or 5-end groups are provided. The disclosed compounds are useful for the treatment of diseases where inhibition of protein expression or correction of aberrant mRNA splice products produces beneficial therapeutic effects.
METHOD FOR PREPARING PHOSPHORUS-CONTAINING LIGAND
A method for preparing a phosphorus-containing ligand is provided, which includes: mixing a phosphorus chloride compound, polypyridine ionic liquid-loaded porous microspheres with a first organic solvent to obtain a first mixture, and mixing a compound in Formula (2) with a second organic solvent to obtain a second mixture,
##STR00001## wherein Z is a multivalent aliphatic hydrocarbon group or a multivalent aromatic hydrocarbon group comprising at least one substituent group, wherein the substituent group is selected from hydrogen atom, halogen atom, C.sub.1-C.sub.10 alkyl group, C.sub.1-C.sub.10 alkoxy group, C.sub.1-C.sub.10 alkanoyl group, aryl group, heteroaryl group, cyano group, or nitro group, and n is an integer from 1 to 8; and mixing the first mixture with the second mixture to make the first mixture react with the second mixture to obtain a reaction mixture, removing generated HCl, filtrating to obtain a filter liquor, and treating the filter liquor to obtain the phosphorus-containing ligand.
METHOD FOR PRODUCING IMIDIC ACID OR IMIDIC ACID SALT
A method for producing an imidic acid or an imidic acid salt having a phosphoryl group by a method for producing an imidic acid or an imidic acid salt represented by the following formula [1], including a reaction of allowing a phosphoryl isocyanate represented by the following formula [2] to react with a compound represented by the following formula [3]:
##STR00001##
METHOD FOR PRODUCING IMIDIC ACID OR IMIDIC ACID SALT
A method for producing an imidic acid or an imidic acid salt having a phosphoryl group by a method for producing an imidic acid or an imidic acid salt represented by the following formula [1], including a reaction of allowing a phosphoryl isocyanate represented by the following formula [2] to react with a compound represented by the following formula [3]:
##STR00001##